TGFβ1 enhances MAD1 expression and stimulates promoter-bound Pol II phosphorylation: Basic functions of C/EBP, SP and SMAD3 transcription factors

BMC Molecular Biology

Volumn 12, Issue , 2011, Pages

  Hein, Nadine ^a,b   Jiang, Kan ^a,c   Cornelissen, Christian ^a   Lüscher, Bernhard ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; HETERODIMER; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDYLTRANSFERASE; POLYMERASE II; PROTEIN MAD1; SMAD3 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR SP; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; DNA DIRECTED DNA POLYMERASE ALPHA; MAD1L1 PROTEIN, HUMAN; NUCLEAR PROTEIN; TGFB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR CELL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; UPREGULATION;

CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL CYCLE PROTEINS; CELL LINE; DNA POLYMERASE II; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SMAD3 PROTEIN; SP1 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 79951857017     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-12-9     Document Type: Article

References (42)

1. Luscher B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 2001, 277(1-2):1-14. 10.1016/S0378-1119(01)00697-7, 11602341.
2. Henriksson M, Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 1996, 68:109-182. full_text, 8712067.
3. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008, 8(12):976-990. 10.1038/nrc2231, 19029958.
4. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev 2008, 22(20):2755-2766. 10.1101/gad.1712408, 2751281, 18923074.
5. Rottmann S, Luscher B. The mad side of the Max network: antagonizing the function of Myc and more. Curr Top Microbiol Immunol 2006, 302:63-122. full_text, 16620026.
6. Foley KP, McArthur GA, Queva C, Hurlin PJ, Soriano P, Eisenman RN. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. Embo J 1998, 17(3):774-785. 10.1093/emboj/17.3.774, 1170426, 9451002.
7. Gehring S, Rottmann S, Menkel AR, Mertsching J, Krippner-Heidenreich A, Luscher B. Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1. Repression of Fas-induced caspase-8 activation. J Biol Chem 2000, 275(14):10413-10420. 10.1074/jbc.275.14.10413, 10744730.
8. Rottmann S, Speckgens S, Luscher-Firzlaff J, Luscher B. Inhibition of apoptosis by MAD1 is mediated by repression of the PTEN tumor suppressor gene. FASEB J 2008, 22(4):1124-1134. 10.1096/fj.07-9627com, 17998413.
9. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Luscher B. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 2001, 15(16):2042-2047. 10.1101/gad.907901, 312761, 11511535.
10. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 1997, 89(3):341-347. 10.1016/S0092-8674(00)80214-7, 9150133.
11. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 1997, 89(3):349-356. 10.1016/S0092-8674(00)80215-9, 9150134.
12. Sommer A, Hilfenhaus S, Menkel A, Kremmer E, Seiser C, Loidl P, Luscher B. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr Biol 1997, 7(6):357-365. 10.1016/S0960-9822(06)00183-7, 9197243.
13. Cultraro CM, Bino T, Segal S. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol Cell Biol 1997, 17(5):2353-2359. 232084, 9111304.
14. Holzel M, Kohlhuber F, Schlosser I, Holzel D, Luscher B, Eick D. Myc/Max/Mad regulate the frequency but not the duration of productive cell cycles. EMBO Rep 2001, 2(12):1125-1132. 10.1093/embo-reports/kve251, 1084169, 11743027.
15. Pulverer B, Sommer A, McArthur GA, Eisenman RN, Luscher B. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. J Cell Physiol 2000, 183(3):399-410. 10.1002/(SICI)1097-4652(200006)183:3<399::AID-JCP13>3.0.CO;2-7, 10797315.
16. Ayer DE, Eisenman RN. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 1993, 7(11):2110-2119. 10.1101/gad.7.11.2110, 8224841.
17. Jiang K, Hein N, Eckert K, Luscher-Firzlaff J, Luscher B. Regulation of the MAD1 promoter by G-CSF. Nucleic Acids Res 2008, 36(5):1517-1531. 10.1093/nar/gkn002, 2275144, 18203738.
18. Larsson LG, Pettersson M, Oberg F, Nilsson K, Luscher B. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 1994, 9(4):1247-1252.
19. Werner S, Beer HD, Mauch C, Luscher B, Werner S. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis. Oncogene 2001, 20(51):7494-7504. 10.1038/sj.onc.1204937, 11709721.
20. Wu S, Hultquist A, Hydbring P, Cetinkaya C, Oberg F, Larsson LG. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity. Exp Cell Res 2009, 315(18):3099-3111. 10.1016/j.yexcr.2009.09.009, 19766114.
21. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009, 21(2):166-176. 10.1016/j.ceb.2009.01.021, 19237272.
22. Massague J. TGFbeta in Cancer. Cell 2008, 134(2):215-230. 10.1016/j.cell.2008.07.001, 18662538.
23. Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 2007, 9(9):1000-1004. 10.1038/ncb434, 17762890.
24. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development 2009, 136(22):3699-3714. 10.1242/dev.030338, 19855013.
25. Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res 2009, 19(1):128-139. 10.1038/cr.2008.328, 2635127, 19114990.
26. Descargues P, Sil AK, Sano Y, Korchynskyi O, Han G, Owens P, Wang XJ, Karin M. IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci USA 2008, 105(7):2487-2492. 10.1073/pnas.0712044105, 2268163, 18268325.
27. Nerlov C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr Opin Cell Biol 2008, 20(2):180-185. 10.1016/j.ceb.2008.02.002, 18358708.
28. Oelgeschlager M, Nuchprayoon I, Luscher B, Friedman AD. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol 1996, 16(9):4717-4725. 231472, 8756629.
29. Margaritis T, Holstege FC. Poised RNA polymerase II gives pause for thought. Cell 2008, 133(4):581-584. 10.1016/j.cell.2008.04.027, 18485867.
30. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007, 130(1):77-88. 10.1016/j.cell.2007.05.042, 17632057.
31. Price DH. Poised polymerases: on your mark...get set...go!. Mol Cell 2008, 30(1):7-10. 10.1016/j.molcel.2008.03.001, 18406322.
32. Sims RJ, Belotserkovskaya R, Reinberg D. Elongation by RNA polymerase II: the short and long of it. Genes Dev 2004, 18(20):2437-2468. 10.1101/gad.1235904, 15489290.
33. Saunders A, Core LJ, Lis JT. Breaking barriers to transcription elongation. Nat Rev Mol Cell Biol 2006, 7(8):557-567. 10.1038/nrm1981, 16936696.
34. Weake VM, Workman JL. Inducible gene expression: diverse regulatory mechanisms. Nat Rev Genet 2010, 11(6):426-437. 10.1038/nrg2781, 20421872.
35. Firzlaff JM, Luscher B, Eisenman RN. Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb protein binding by the E7 protein of human papillomavirus type 16. Proc Natl Acad Sci USA 1991, 88(12):5187-5191. 10.1073/pnas.88.12.5187, 51837, 2052600.
36. Verbeek W, Gombart AF, Chumakov AM, Muller C, Friedman AD, Koeffler HP. C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. Blood 1999, 93(10):3327-3337.
37. Rotheneder H, Geymayer S, Haidweger E. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. J Mol Biol 1999, 293(5):1005-1015. 10.1006/jmbi.1999.3213, 10547281.
38. Bousset K, Oelgeschlager MH, Henriksson M, Schreek S, Burkhardt H, Litchfield DW, Luscher-Firzlaff JM, Luscher B. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II. Cell Mol Biol Res 1994, 40(5-6):501-511.
39. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296(5567):550-553. 10.1126/science.1068999, 11910072.
40. Hagen G, Muller S, Beato M, Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 1994, 13(16):3843-3851. 395297, 8070411.
41. Oelgeschlager M, Janknecht R, Krieg J, Schreek S, Luscher B. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. Embo J 1996, 15(11):2771-2780. 450213, 8654374.
42. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96(5):701-712. 10.1016/S0092-8674(00)80580-2, 10089885.